Development of the Sm14/GLA-SE - schistosomiasis vaccine candidate: An open, not placebo-controlled, standardized dose immunization phase Ib clinical trial targeting healthy young women
Marilia Santini-Oliveira, View ORCID ProfilePatrícia Machado Pinto, Tatiane dos Santos, Monica Magno Vilar, View ORCID ProfileBeatriz Grinsztejn, Valdilea Veloso, Elan C. Paes-de-Almeida, View ORCID ProfileMaria A. Z. Amaral, Celso R. Ramos, Miryam Marroquin-Quelopana, Rhea Coler, Steven Reed, Marcia Ciol, Wilson Savino, Juçara de Carvalho Parra, View ORCID ProfileMarília Sirianni dos Santos Almeida, View ORCID ProfileMiriam Tendler
doi: https://doi.org/10.1101/2022.08.17.22278904
Marilia Santini-Oliveira
1Evando Chagas National Institute of Infectology, Fiocruz, Rio de Janeiro, 21045-900, Brazil
Patrícia Machado Pinto
2Laboratory of Experimental Schistosomiasis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Av. Brasil, n°4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil
Tatiane dos Santos
2Laboratory of Experimental Schistosomiasis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Av. Brasil, n°4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil
Monica Magno Vilar
2Laboratory of Experimental Schistosomiasis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Av. Brasil, n°4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil
Beatriz Grinsztejn
1Evando Chagas National Institute of Infectology, Fiocruz, Rio de Janeiro, 21045-900, Brazil
Valdilea Veloso
1Evando Chagas National Institute of Infectology, Fiocruz, Rio de Janeiro, 21045-900, Brazil
Elan C. Paes-de-Almeida
3Department of Basic Sciences, Fluminense Federal University, Nova Friburgo, RJ, Brazil
Maria A. Z. Amaral
4Program for Development of the Mata Atlântica Campus, Fiocruz, Rio de Janeiro, Brazil
Celso R. Ramos
5Fenix Biotec Treinamento SS LTDA, São Paulo, Brazil
Miryam Marroquin-Quelopana
5Fenix Biotec Treinamento SS LTDA, São Paulo, Brazil
Rhea Coler
6Department of Global Health, University of Washington, Seattle, USA
Steven Reed
7HDT Bio, Seattle, USA
Marcia Ciol
8Department of Rehabilitation Medicine, School of Medicine, University of Washington, Seattle, USA
Wilson Savino
9Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
10Brazilian National Institute of Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
Juçara de Carvalho Parra
11René Rachou Institute — Fiocruz Minas, Oswaldo Cruz Foundation, Belo Horizonte, Brazil
Marília Sirianni dos Santos Almeida
2Laboratory of Experimental Schistosomiasis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Av. Brasil, n°4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil
Miriam Tendler
2Laboratory of Experimental Schistosomiasis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Av. Brasil, n°4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil
Article usage
Posted August 19, 2022.
Development of the Sm14/GLA-SE - schistosomiasis vaccine candidate: An open, not placebo-controlled, standardized dose immunization phase Ib clinical trial targeting healthy young women
Marilia Santini-Oliveira, Patrícia Machado Pinto, Tatiane dos Santos, Monica Magno Vilar, Beatriz Grinsztejn, Valdilea Veloso, Elan C. Paes-de-Almeida, Maria A. Z. Amaral, Celso R. Ramos, Miryam Marroquin-Quelopana, Rhea Coler, Steven Reed, Marcia Ciol, Wilson Savino, Juçara de Carvalho Parra, Marília Sirianni dos Santos Almeida, Miriam Tendler
medRxiv 2022.08.17.22278904; doi: https://doi.org/10.1101/2022.08.17.22278904
Development of the Sm14/GLA-SE - schistosomiasis vaccine candidate: An open, not placebo-controlled, standardized dose immunization phase Ib clinical trial targeting healthy young women
Marilia Santini-Oliveira, Patrícia Machado Pinto, Tatiane dos Santos, Monica Magno Vilar, Beatriz Grinsztejn, Valdilea Veloso, Elan C. Paes-de-Almeida, Maria A. Z. Amaral, Celso R. Ramos, Miryam Marroquin-Quelopana, Rhea Coler, Steven Reed, Marcia Ciol, Wilson Savino, Juçara de Carvalho Parra, Marília Sirianni dos Santos Almeida, Miriam Tendler
medRxiv 2022.08.17.22278904; doi: https://doi.org/10.1101/2022.08.17.22278904
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2885)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12626)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4487)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2870)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4254)
- Nursing (228)
- Nutrition (622)
- Oncology (2229)
- Ophthalmology (635)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6834)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)